EP4562006A1 - N-heterocyclische gpcr-rezeptoragonisten, pharmazeutische zusammensetzungen damit und verfahren zu ihrer verwendung - Google Patents

N-heterocyclische gpcr-rezeptoragonisten, pharmazeutische zusammensetzungen damit und verfahren zu ihrer verwendung

Info

Publication number
EP4562006A1
EP4562006A1 EP23755311.0A EP23755311A EP4562006A1 EP 4562006 A1 EP4562006 A1 EP 4562006A1 EP 23755311 A EP23755311 A EP 23755311A EP 4562006 A1 EP4562006 A1 EP 4562006A1
Authority
EP
European Patent Office
Prior art keywords
lvii
certain embodiments
methyl
lxiv
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23755311.0A
Other languages
English (en)
French (fr)
Inventor
Xiaohui Du
Ray FUCINI
Sumanta GARAI
Xiang Zhou
Chien-Hung Yeh
Joseph Vacca
David Lloyd
Stig Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carmot Therapeutics Inc
Original Assignee
Carmot Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmot Therapeutics Inc filed Critical Carmot Therapeutics Inc
Publication of EP4562006A1 publication Critical patent/EP4562006A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Definitions

  • N-HETEROCYLIC GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE FIELD [0001]
  • GLP-1 receptor modulator compounds are provided herein; pharmaceutical compositions comprising the compounds; methods of producing the compounds; and methods of using the compounds, and compositions for therapy.
  • the compounds, and compositions are useful, for instance, in methods of treatment, and prevention of metabolic diseases or conditions, methods of detection of metabolic diseases or conditions, and methods of diagnosis of metabolic diseases or conditions.
  • BACKGROUND [0002] Diabetes is a serious chronic disease that occurs when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces.
  • Complications of diabetes include, damage to the heart, blood vessels, eyes, kidneys, and nerves. Diabetes can increase risk of heart disease, and stroke. The results include serious effects on quality of life, health, and mortality. WHO Global Report on Diabetes, 2016, World Health Organization. As of 2017, approximately 462 million individuals worldwide, about 6.28% of the population was affected by type 2 diabetes, and this prevalence was increasing measurably. Khan et al., 2020, J. Epidemiol. Glob. Health 10(1):107-111. The global economic burden of diabetes in 2015 was estimated to be $1.3T, and estimated to increase to $2.1T by 2030. Bommer et al., 2018, Diabetes Care 41(5):963-970. Approximately 90-95% of all diabetes cases are type 2 diabetes.
  • GLP-1 receptor The glucagon-like peptide-1 receptor (GLP-1 receptor, or GLP1R) has emerged as a potential target for treating type 2 diabetes. Its ligand, glucagon-like peptide-1 (GLP-1) enhances glucose-induced insulin secretion, and increases insulin synthesis among many other effects. Doyle and Egan, 2007, Pharmacol. Ther.113(3):546-593. GLP-1 is known to delay gastric emptying, suppress food intake, increase satiety, and reduce weight in humans. Shah and Vella, 2014 Rev Endocr Metab Disord.15(3): 181–187.
  • GLP-1 receptor Activating the GLP-1 receptor has been shown to have beneficial effects on insulin secretion and the maintenance of beta cell glucose sensing, transcription, synthesis, proliferation, and survival. Doyle and Egan, 2007, supra. While the GLP-1 receptor is a promising therapeutic target, only a handful of GLP-1 receptor drugs have been approved to date, and most, or all of these are peptide, or polypeptide drugs. [0004] There is a need for additional therapies for treating metabolic diseases, and conditions, like type 2 diabetes. Small molecules targeting GLP-1 receptor should provide safe, stable, and easy to administer therapeutics for metabolic diseases, and conditions such as type 2 diabetes.
  • the compounds of Formula (LVII)-(LXIV), and embodiments thereof, are useful for modulating the activity of GLP-1 receptor.
  • the compounds can be used to agonize the activity of GLP-1 receptor.
  • the compounds can be used for treating diseases, or conditions modulated by GLP-1 receptor.
  • B 4 is -CH-, -C(R 2 )-, or -N-;
  • D 1 is -CH-or -N-;
  • D 2 is -CH-, -N-, -C(CH 3 )-;
  • D 4 is -CH- or -N-;
  • L 1 is selected from the group consisting of -O-, -CH 2 -, -NH-, -N(Me)-, -N(Et)-, - OCH2-, -OC(H,Me)-, -CH2O-, -NHCH2-, -CH2NH-, -N(Me)CH2-, and -SO2NH
  • R 3 is independently selected from the group consisting of -CH 2 CH 3 , -CH 2 F, -CH 2 CN, and -CF 3 ; and all the other variables are as in Formula (LVII); wherein when B 4 is -C- and R 3 is -CH2F, -N- and R 3 is -CH 2 F, then the compound is not .
  • the variables are as in Formula (LVII).
  • R 4 is selected from the group consisting of: (1,1-dioxidothietan-2-yl)methyl, ((R)-1,1- dioxidothietan-2-yl)methyl, ((S)-1,1-dioxidothietan-2-yl)methyl, , other variables are as in Formula (LVII).
  • the compound is according to Formula (LXI), and all the other variables are as in Formula (LVII).
  • L 1 is selected from the group consisting of -NH-, -N(Me)-, -N(Et)-, -OCH 2 -, -OC(H,Me)-, -CH 2 O-, -OCH 2 (cyclopropyl)-, -O-CH 2 -CH 2 -, -CH 2 -O-CH 2 -, - CH2-O-C((CH3)2), -NHCH2-, -N(Me)CH2-, and -SO2NH-.
  • the compounds are useful in methods of treatment and prevention of metabolic diseases, and conditions, methods of detection of metabolic diseases, and conditions, and methods of diagnosis of metabolic diseases, and conditions.
  • compositions comprising a compound of Formula (LVII) - (LXIV).
  • the compositions are pharmaceutical compositions. Any suitable pharmaceutical composition may be used.
  • a kit comprising the compound of Formula (LVII) - (LXIV), or embodiments thereof, or a pharmaceutical composition thereof.
  • the methods are analytical methods.
  • the compounds, or compositions described herein are used to treat a disease, or condition.
  • the disease, or condition is selected from metabolic diseases, or conditions.
  • the disease is type 2 diabetes.
  • the use of compounds described herein, and compositions thereof, for the treatment of type 2 diabetes. DEATILED DESCRIPTION [0021] Described herein are GLP-1 receptor compounds useful for treating metabolic diseases or conditions, such as type 2 diabetes.
  • the term “about” indicates and encompasses an indicated value, and a range above and below that value. In certain embodiments, the term “about” indicates the designated value ⁇ 10%, ⁇ 5%, or ⁇ 1%. In certain embodiments, the term “about” indicates the designated value ⁇ one standard deviation of that value. In certain embodiments, for example, logarithmic scales (e.g., pH), the term “about” indicates the designated value ⁇ 0.3, ⁇ 0.2, or ⁇ 0.1. [0025] When referring to the compounds provided herein, the following terms have the following meanings unless indicated otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as is commonly understood by one of ordinary skill in the art.
  • Alkoxy and alkoxyl refer to the group –OR′′ where R′′ is alkyl or cycloalkyl. Alkoxy groups include, in certain embodiments, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, tert-butoxy, sec-butoxy, n-pentoxy, n-hexoxy, 1,2-dimethylbutoxy, and the like.
  • alkoxyamine refers to the group -alkylene-O-NH2, wherein alkylene is as defined herein.
  • alkoxyamine groups can react with aldehydes to form oxime residues.
  • alkoxyamine groups include -CH 2 CH 2 -O-NH 2 and -CH 2 -O-NH 2 .
  • alkyl refers to a saturated straight, or branched hydrocarbon.
  • the alkyl group is a primary, secondary, or tertiary hydrocarbon.
  • the alkyl group includes one to ten carbon atoms (i.e., C1 to C10 alkyl).
  • the alkyl is a lower alkyl, for example, C1-6 alkyl, and the like.
  • the alkyl group is selected from the group consisting of methyl, ethyl, propyl, isopropyl, butyl, isobutyl, secbutyl, t-butyl, pentyl, isopentyl, neopentyl, hexyl, isohexyl, 3-methylpentyl, 2,2-dimethylbutyl, and 2,3- dimethylbutyl.
  • substituted alkyl refers to an alkyl substituted with one, two, or three groups independently selected from a halogen (e.g., fluoro (F), chloro (Cl), bromo (Br), or iodo (I)), alkyl, haloalkyl, hydroxyl, amino, alkylamino, alkoxy, aryl, heteroaryl, cycloalkyl, cyano, oxo, alkyne, and heterocycloalkylalkylene. In some embodiments, alkyl is unsubstituted.
  • a halogen e.g., fluoro (F), chloro (Cl), bromo (Br), or iodo (I)
  • alkyl haloalkyl
  • hydroxyl amino, alkylamino, alkoxy, aryl, heteroaryl, cycloalkyl, cyano, oxo, alkyne, and heterocycloalkylal
  • alkylene refers to a divalent alkyl group, as defined herein. “Substituted alkylene” refers to an alkylene group substituted as described herein for alkyl. In some embodiments, alkylene is unsubstituted.
  • Alkenyl refers to an olefinically unsaturated hydrocarbon group, in certain embodiments, having up to about eleven carbon atoms, or from two to six carbon atoms (e.g., “lower alkenyl”), which can be straight-chained or branched, and having at least one, or from one to two sites of olefinic unsaturation.
  • Substituted alkenyl refers to an alkenyl group substituted as described herein for alkyl.
  • Alkenylene refers to a divalent alkenyl as defined herein. Lower alkenylene is, for example, C 2 -C 6 -alkenylene.
  • Alkynyl refers to acetylenically unsaturated hydrocarbon groups, in certain embodiments, having up to about eleven carbon atoms, or from two to six carbon atoms (e.g., “lower alkynyl”), which can be straight-chained or branched, and having at least one, or from one to two sites of acetylenic unsaturation.
  • alkynyl groups include acetylene (-C ⁇ CH), propargyl (-CH2C ⁇ CH), and the like. “Substituted alkynyl” refers to an alkynyl group substituted as described herein for alkyl. [0033] “Alkynylene” refers to a divalent alkynyl as defined herein. Lower alkynylene is, for example, C 2 -C 6 -alkynylene. [0034] “Amino” refers to -NH2.
  • alkylamino refers to the group –NHR′′ where R′′ is, for example, C1-10alkyl, as defined herein. In certain embodiments, alkylamino is C 1-6 alkylamino.
  • dialkylamino refers to the group –NR′′R′′ where, each R′′ is independently C1-10alkyl, as defined herein. In certain embodiments, dialkylamino is di-C1-6alkylamino.
  • aryl refers to phenyl, biphenyl, or naphthyl.
  • aryl group can be substituted with any described moiety including, but not limited to, one or more moieties (e.g., in some embodiments one, two, or three moieties) selected from the group consisting of halogen (e.g., fluoro (F), chloro (Cl), bromo (Br), or iodo (I)), alkyl, haloalkyl, hydroxyl, amino, alkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfonic acid, sulfate, phosphonic acid, phosphate, and phosphonate, wherein each moiety is independently either unprotected, or protected as necessary, as would be appreciated by those skilled in the art (e.g., Greene, et al., Protective Groups in Organic Synthesis, John Wiley and Sons, Second Edition, 1991); and wherein the aryl in the
  • arylamino refers to an -NR′R′′ group where R′ is hydrogen, or C1-C6-alkyl; and R′′ is aryl, as defined herein.
  • arylene refers to a divalent aryl group, as defined herein.
  • aryloxy refers to an -OR group where R is aryl, as defined herein.
  • Alkarylene refers to an arylene group, as defined herein, wherein the aryl ring is substituted with one or two alkyl groups.
  • Substituted alkarylene refers to an alkarylene, as defined herein, where the arylene group is further substituted, as defined herein for aryl.
  • “Aralkylene” refers to an -alkyl-arylene- or arylene-alkyl, for instance, a -C1-C2 alkyl-arylene-, -arylene-C 1 -C 2 alkyl-, or - C 1 -C 2 alkyl-arylene-C 1 -C 2 alkyl- group, where arylene is as defined herein.
  • Substituted aralkylene refers to an aralkylene, as defined herein, where the aralkylene group is substituted, as defined herein for aryl.
  • Substituted C 1 - C2 alkyl refers to a C1-C2 alkyl group that is substituted as defined herein for an alkyl.
  • Arylalkylene refers to -alkyl-arylene- or arylene-alkyl, for instance, a -C 1 -C 2 alkyl-arylene-, -arylene-C1-C2 alkyl-, or -C1-C2 alkyl-arylene-C1-C2 alkyl- group, where arylene is as defined herein.
  • Substituted arylalkylene refers to an arylalkylene, as defined herein, where the arylalkylene group is substituted, as defined herein for aryl.
  • Substituted C 1 -C 2 alkyl refers to a C 1 -C 2 alkyl group that is substituted as defined herein for an alkyl.
  • Carboxyl or “carboxy” refers to -C(O)OH or -COOH.
  • cycloalkyl refers to a saturated cyclic hydrocarbon. In certain embodiments, the cycloalkyl group may be a saturated, and/or bridged, and/or non-bridged, and/or a fused bicyclic group.
  • the cycloalkyl group includes three to ten carbon atoms (i.e., C3 to C10 cycloalkyl). In some embodiments, the cycloalkyl has from three to fifteen carbons (C 3-15 ), from three to ten carbons (C3-10), from three to seven carbons (C3-7), or from three to six carbons (C 3 -C 6 ) (i.e., “lower cycloalkyl”).
  • the cycloalkyl group is cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexylmethyl, cycloheptyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptyl, decalinyl, or adamantyl.
  • cycloalkylene refers to a divalent cycloalkyl group, as defined herein.
  • the cycloalkylene group is cyclopropylene , cyclobutylene , cyclopentylene , cyclohexylene , cycloheptylene , and the like.
  • Lower cycloalkylene refers to a C 3 -C 6 -cycloalkylene.
  • cycloalkylalkyl refers to an alkyl group, as defined herein, substituted with one or two cycloalkyl, as defined herein.
  • haloalkyl refers to an alkyl group, as defined herein, substituted with one, or more halogen atoms (e.g., in some embodiments one, two, three, four, or five) which are independently selected.
  • heteroalkyl refers to an alkyl, as defined herein, in which one or more carbon atoms are replaced by heteroatoms.
  • heteroalkenyl refers to an alkenyl, as defined herein, in which one, or more carbon atoms are replaced by heteroatoms.
  • heteroalkynyl refers to an alkynyl, as defined herein, in which one, or more carbon atoms are replaced by heteroatoms. Suitable heteroatoms include, but are not limited to, nitrogen (N), oxygen (O), and sulfur (S) atoms. Heteroalkyl, heteroalkenyl, and heteroalkynyl are optionally substituted. Examples of heteroalkyl moieties include, but are not limited to, aminoalkyl, sulfonylalkyl, and sulfinylalkyl. Examples of heteroalkyl moieties also include, but are not limited to, methylamino, methylsulfonyl, and methylsulfinyl.
  • Substituted heteroalkyl refers to heteroalkyl substituted with one, two, or three groups independently selected from halogen (e.g., fluoro (F), chloro (Cl), bromo (Br), or iodo (I)), alkyl, haloalkyl, hydroxyl, amino, alkylamino, and alkoxy.
  • a heteroalkyl group may comprise one, two, three, or four heteroatoms.
  • heteroalkylene refers to a divalent heteroalkyl, as defined herein.
  • substituted heteroalkylene refers to a divalent heteroalkyl, as defined herein, substituted as described for heteroalkyl.
  • heterocycloalkyl refers to a monovalent, monocyclic, or multicyclic non-aromatic ring system, wherein one, or more of the ring atoms are heteroatoms independently selected from oxygen (O), sulfur (S), and nitrogen (N) (e.g., where the nitrogen, or sulfur atoms may be optionally oxidized, and the nitrogen atoms may be optionally quaternized) and the remaining ring atoms of the non-aromatic ring are carbon atoms.
  • heterocycloalkyl is a monovalent, monocyclic, or multicyclic fully-saturated ring system.
  • the heterocycloalkyl group has from three to twenty, from three to fifteen, from three to ten, from three to eight, from four to seven, from four to eleven, or from five to six ring atoms.
  • the heterocycloalkyl may be attached to a core structure at any heteroatom or carbon atom which results in the creation of a stable compound.
  • the heterocycloalkyl is a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include a fused or bridged ring system and in which the nitrogen or sulfur atoms may be optionally oxidized, and/or the nitrogen atoms may be optionally quaternized.
  • heterocycloalkyl radicals include, but are not limited to, 2,5-diazabicyclo[2.2.2]octanyl, decahydroisoquinolinyl, dihydrobenzisoxazinyl, dihydrofuryl, dihydroisoindolyl, dihydropyranyl, dihydropyrazolyl, dihydropyrazinyl, dihydropyridinyl, dihydropyrimidinyl, dihydropyrrolyl, dioxolanyl, 1,4-dithianyl, furanonyl, imidazolidinyl, imidazolinyl, indolinyl, isothiazolidinyl, isoxazolidinyl, morpholinyl, octahydroindolyl, octahydroisoindolyl, oxazolidinonyl, oxazolidinyl, oxiranyl, piperaz
  • heterocycloalkyl may also be optionally substituted as described herein.
  • heterocycloalkyl is substituted with one, two, or three groups independently selected from halogen (e.g., fluoro (F), chloro (Cl), bromo (Br), or iodo (I)), alkyl, haloalkyl, hydroxyl, amino, alkylamino, oxo, cyano, and alkoxy.
  • a heterocycloalkyl group may comprise one, two, three, or four heteroatoms.
  • heterocycloalkylene refers to a divalent heterocycloalkyl as defined herein.
  • heteroaryl refers to a monovalent monocyclic aromatic group, and/or multicyclic aromatic group, wherein at least one aromatic ring contains one, or more heteroatoms independently selected from oxygen, sulfur, and nitrogen in the ring.
  • Each ring of a heteroaryl group can contain one, or two oxygen atoms, one, or two sulfur atoms, and/or one to four nitrogen atoms, provided that the total number of heteroatoms in each ring is four, or less and each ring contains at least one carbon atom.
  • the heteroaryl has from five to twenty, from five to fifteen, or from five to ten ring atoms.
  • a heteroaryl may be attached to the rest of the molecule via a nitrogen or a carbon atom.
  • monocyclic heteroaryl groups include, but are not limited to, furanyl, imidazolyl, isothiazolyl, isoxazolyl, oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, triazolyl, thiadiazolyl, thiazolyl, thienyl, tetrazolyl, and triazinyl.
  • bicyclic heteroaryl groups include, but are not limited to, benzofuranyl, benzimidazolyl, benzoisoxazolyl, benzopyranyl, benzothiadiazolyl, benzothiazolyl, benzothienyl, benzotriazolyl, benzoxazolyl, furopyridyl, imidazopyridinyl, imidazothiazolyl, indolizinyl, indolyl, indazolyl, isobenzofuranyl, isobenzothienyl, isoindolyl, isoquinolinyl, naphthyridinyl, oxazolopyridinyl, phthalazinyl, pteridinyl, purinyl, pyridopyridyl, pyrrolopyridyl, quinolinyl, quinoxalinyl, quinazolinyl, thiadiazolopyrimidyl, and thi
  • tricyclic heteroaryl groups include, but are not limited to, acridinyl, benzindolyl, carbazolyl, dibenzofuranyl, perimidinyl, phenanthrolinyl, phenanthridinyl, phenarsazinyl, phenazinyl, phenothiazinyl, phenoxazinyl, and xanthenyl.
  • heteroaryl may also be optionally substituted as described herein.
  • “Substituted heteroaryl” is a heteroaryl substituted as defined for aryl.
  • heteroarylene refers to a divalent heteroaryl group, as defined herein.
  • heteroarylene is a heteroarylene substituted as defined for aryl.
  • heteroarylalkylene refers to -alkyl-heteroarylene- or -heteroarylene- alkyl, for instance, a a -C1-C2 alkyl-heteroarylene-, -heteroarylene-C1-C2 alkyl-, or -C1-C2 alkyl-heteroarylene-C1-C2 alkyl- group, where heteroarylene is as defined herein.
  • “Substituted heteroarylalkylene” refers to a heteroarylalkylene, as defined herein, where the heteroarylalkylene group is substituted, as defined herein for aryl.
  • “Substituted C1-C2 alkyl” refers to a C 1 -C 2 alkyl group that is substituted as defined herein for an alkyl.
  • the term “protecting group,” as used herein, and unless otherwise specified, refers to a group that is added to an oxygen, nitrogen, or phosphorus atom to prevent its further reaction, or for other purposes.
  • “Pharmaceutically acceptable salt” refers to any salt of a compound provided herein which retains its biological properties, and which is not toxic or otherwise undesirable for pharmaceutical use. Such salts may be derived from a variety of organic, and inorganic counter-ions well known in the art.
  • Such salts include, but are not limited to (1) acid addition salts formed with organic, or inorganic acids such as hydrochloric, hydrobromic, sulfuric, nitric, phosphoric, sulfamic, acetic, trifluoroacetic, trichloroacetic, propionic, hexanoic, cyclopentylpropionic, glycolic, glutaric, pyruvic, lactic, malonic, succinic, sorbic, ascorbic, malic, maleic, fumaric, tartaric, citric, benzoic, 3-(4-hydroxybenzoyl)benzoic, picric, cinnamic, mandelic, phthalic, lauric, methanesulfonic, ethanesulfonic, 1,2-ethane-disulfonic, 2-hydroxyethanesulfonic, benzenesulfonic, 4-chlorobenzenesulfonic, 2-naphthalenesulfonic, 4-to
  • Pharmaceutically acceptable salts further include, by way of example and without limitation, sodium, potassium, calcium, magnesium, ammonium, and tetraalkylammonium salts, and the like, and when the compound contains a basic functionality, salts of non-toxic organic, or inorganic acids, such as hydrohalides, for example, hydrochloride and hydrobromide, sulfate, phosphate, sulfamate, nitrate, acetate, trifluoroacetate, trichloroacetate, propionate, hexanoate, cyclopentylpropionate, glycolate, glutarate, pyruvate, lactate, malonate, succinate, sorbate, ascorbate, malate, maleate, fumarate, tartarate, citrate, benzoate, 3-(4-hydroxybenzoyl)benzoate, picrate, cinnamate, mandelate, phthalate, laurate, methanesulfonate (mesylate), hydrohal
  • the term “substantially free of” or “substantially in the absence of” with respect to a composition refers to a composition that includes at least 85%, or 90% by weight, in certain embodiments 95%, 98 %, 99%, or 100% by weight; or in certain embodiments, 95%, 98%, 99%, or 100% of the designated enantiomer or diastereomer of a compound.
  • the compounds are substantially free of one of two enantiomers.
  • the compounds are substantially free of one of two diastereomers.
  • the compounds are substantially free of enantiomers (i.e., a racemic, or 50:50 mixture of compounds).
  • isolated refers to a composition that includes at least 85%, 90%, 95%, 98%, or 99% to 100% by weight, of the compound, the remainder comprising other chemical species, enantiomers or diastereomers.
  • Solvate refers to a compound provided herein, or a salt thereof, that further includes a stoichiometric, or non-stoichiometric amount of solvent bound by non-covalent intermolecular forces.
  • the solvate is a hydrate.
  • “Isotopic composition” refers to the amount of each isotope present for a given atom
  • “natural isotopic composition” refers to the naturally occurring isotopic composition, or abundance for a given atom.
  • Atoms containing their natural isotopic composition may also be referred to herein as “non-enriched” atoms. Unless otherwise designated, the atoms of the compounds recited herein are meant to represent any stable isotope of that atom. For example, unless otherwise stated, when a position is designated specifically as hydrogen (H), the position is understood to have hydrogen at its natural isotopic composition.
  • H hydrogen
  • Isotopic enrichment refers to the percentage of incorporation of an amount of a specific isotope at a given atom in a molecule in the place of that atom’s natural isotopic abundance.
  • deuterium (D) enrichment of 1% at a given position means that 1% of the molecules in a given sample contain deuterium at the specified position. Because the naturally occurring distribution of deuterium is about 0.0156%, deuterium enrichment at any position in a compound synthesized using non-enriched starting materials is about 0.0156%.
  • the isotopic enrichment of the compounds provided herein can be determined using conventional analytical methods known to one of ordinary skill in the art, including mass spectrometry and nuclear magnetic resonance spectroscopy.
  • “Isotopically enriched” refers to an atom having an isotopic composition other than the natural isotopic composition of that atom. “Isotopically enriched” may also refer to a compound containing at least one atom having an isotopic composition other than the natural isotopic composition of that atom.
  • alkyl, alkylene, alkylamino,” “dialkylamino,” “cycloalkyl,” “aryl,” “arylene,” “alkoxy,” “amino,” “carboxyl,” “heterocycloalkyl,” “heteroaryl,” “heteroarylene,” “carboxyl,” and “amino acid” groups optionally comprise deuterium (D) at one, or more positions where hydrogen (H) atoms are present, and wherein the deuterium composition of the atom or atoms is other than the natural isotopic composition.
  • alkyl optionally comprise carbon-13 ( 13 C) at an amount other than the natural isotopic composition.
  • EC50 refers to a dosage, concentration, or amount of a particular test compound that elicits a dose-dependent response at 50% of maximal expression of a particular response that is induced, provoked, or potentiated by the particular test compound.
  • IC50 refers to an amount, concentration, or dosage of a particular test compound that achieves a 50% inhibition of a maximal response in an assay that measures such response.
  • subject and “patient” are used interchangeably.
  • subject refers to an animal, such as a mammal including a non-primate (e.g., a cow, pig, horse, cat, dog, rat, and mouse), and a primate (e.g., a monkey, such as a cynomolgous monkey, a chimpanzee, and a human), and in certain embodiments, a human.
  • a non-primate e.g., a cow, pig, horse, cat, dog, rat, and mouse
  • a primate e.g., a monkey, such as a cynomolgous monkey, a chimpanzee, and a human
  • the subject is a farm animal (e.g., a horse, a cow, a pig, etc.), or a pet (e.g., a dog or a cat).
  • the subject is a human.
  • the terms “therapeutic agent”, and “therapeutic agents” refer to any agent(s) which can be used in the treatment, or prevention of a disorder, or one or more symptoms thereof.
  • the term “therapeutic agent” includes a compound provided herein.
  • a therapeutic agent is an agent which is known to be useful for, or has been, or is currently being used for the treatment, or prevention of a disorder, or one, or more symptoms thereof.
  • “Therapeutically effective amount” refers to an amount of a compound, or composition that, when administered to a subject for treating a condition, is sufficient to effect such treatment for the condition.
  • a “therapeutically effective amount” can vary depending on, inter alia, the compound, the disease or disorder, and its severity, and the age, weight, etc., of the subject to be treated.
  • “Treating” or “treatment” of any disease, or disorder refers, in certain embodiments, to ameliorating a disease, or disorder that exists in a subject.
  • “treating”, or “treatment” includes ameliorating at least one physical parameter, which may be indiscernible by the subject.
  • “treating”, or “treatment” includes modulating the disease, or disorder, either physically (e.g., stabilization of a discernible symptom), or physiologically (e.g., stabilization of a physical parameter), or both.
  • “treating”, or “treatment” includes delaying, or preventing the onset of the disease, or disorder, or delaying, or preventing recurrence of the disease, or disorder. In yet another embodiment, “treating”, or “treatment” includes the reduction or elimination of either the disease, or disorder, or retarding the progression of the disease, or disorder, or of one, or more symptoms of the disease, or disorder, or reducing the severity of the disease, or disorder, or of one, or more symptoms of the disease, or disorder. [0075] As used herein, the terms “prophylactic agent”, and “prophylactic agents” as used refer to any agent(s) which can be used in the prevention of a disorder, or one or more symptoms thereof.
  • the term “prophylactic agent” includes a compound provided herein. In certain other embodiments, the term “prophylactic agent” does not refer a compound provided herein.
  • a prophylactic agent is an agent which is known to be useful for, or has been or is currently being used to prevent, or impede the onset, development, progression, and/or severity of a disorder.
  • prophylactically effective amount refers to the amount of a therapy (e.g., prophylactic agent) which is sufficient to result in the prevention, or reduction of the development, recurrence, or onset of one or more symptoms associated with a disorder, or to enhance or improve the prophylactic effect(s) of another therapy (e.g., another prophylactic agent).
  • a therapy e.g., prophylactic agent
  • Compounds of Formulae (LVII)-(LXIV) are GLP-1 receptor compounds useful for modulating one, or more properties of GLP-1 receptor.
  • the compounds can be prepared as described herein and used for therapy, or diagnosis.
  • the therapy is the treatment of a metabolic disease or condition.
  • the therapy is the treatment of type 2 diabetes.
  • the embodiments described herein include the recited compounds as well as pharmaceutically acceptable salts, hydrates, solvates, stereoisomers, tautomers, and/or mixtures thereof.
  • the compound of Formula (LVII) is selected from compounds 554, 566, 567, 595, 597, 602-611, 613, 615-617, 619, 620, 622, 624-632, and 634-636 in Table 2.
  • B 4 is -C- and R 3 is -CH 2 F, then the compound accordingly to Formula (LVIII) is not .
  • B 4 is -N- and R 3 is -CH 2 F, then the compound accordingly to Formula (LVIII) is not .
  • the compound of Formula (LVIII) is selected from compounds 555, 557, 586, 587, and 599 in Table 2.
  • a compound of Formula (LIX), or a pharmaceutically acceptable salt, or stereoisomer thereof LIX wherein: D 1 is -CH- or -N-; D 2 is -CH-, -N-, or -C(CH3)-; D 4 is -CH- or -N-; L 1 is selected from the group consisting of -O-, -CH2-, -NH-, -N(Me)-, -N(Et)-, - OCH 2 -, -OC(H,Me)-, -CH 2 O-, -CH 2 NH-, -NHCH 2 -, -N(Me)CH 2 -, and -SO 2 NH-; L 2 is selected from the group consisting of a bond, -C(O)-
  • the compound of Formula (LIX) is compound 571 in Table 2.
  • the compound of Formula (LX) is selected from compounds 570, 575, 579, 582, 583, 584, 588, 589-592, 600, 601, 612, 618, and 621 in Table 2.
  • a compound of Formula (LXIII ), or a pharmaceutically acceptable salt, or stereoisomer thereof: LXI wherein D 1 is -CH- or -N-; D 2 is -CH-, -N-, or -C(CH3)-; D 4 is -CH- or -N-; L 2 is selected from the group consisting of a bond, -C(O)-, -CH2-, -C(H) , SO2-, - each R 1 is independently selected from the group consisting of alkyl, substituted alkyl, halo, cyano, azido, alkoxy, haloalkoxy, and R 11 R 12 NCO-; each R 2 is independently selected from
  • the compound of Formula (LXI) is compound 614 in Table 2.
  • a compound of Formula (LXII) is option (a), (b), (c), (d), or (e).
  • option (a) when D 1 is -N- and D 2 and D 4 are -CH-, then the compound is not one of the following compounds.
  • option (d), D 1 , D 2 , and D 4 are -CH- and R 5 is selected from group consisting of:-H, -CH 2 OH - CH3 or -cyclopropyl.
  • option (e), D 1 , D 2 , and D 4 are -CH- and L 3 is - C(H)CH3-.
  • option (e) zero or one of D 1 , D 2 , and D 4 is -N- and L 3 is -C(H)CH3-.
  • the compound of Formula (LXII) is selected from compounds 556, 559, 560, 563-565, 568, 569, 574, 580, 585, 623, 633, and 637-639 in Table .
  • a compound of any of Formulas (LVII - LXIV), or a pharmaceutically salt, tautomer, stereoisomer, and/or mixture of stereoisomers thereof wherein R 4 is selected from the group consisting of azetidine-3-yl-methyl, (3R)- azetidine-3-yl-methyl, (3S)-azetidine-3-yl-methyl, (S)-buta-4-yl-1,3-diol, butan-1-yl-one, 1- (cyanomethyl)-cycloprop-1-yl-methyl, 3-(difluoromethyl)oxetan-3-yl-methyl, (1,1- dioxidothietan-2-yl)methyl, ((R)-1,1-dioxidothietan-2-yl)methyl, ((S)-1,1-dioxidothietan-2- yl)methyl, (1-ethyl-1H-imida
  • R 4 is oxetan-2-yl-methyl.
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • a compound of any of Formulas (LVII - LXIV), or a pharmaceutically salt, tautomer, stereoisomer, and/or mixture of stereoisomers thereof wherein R 4 is selected from the group consisting of (S)-buta-4-yl-1,3-diol, butan-1- yl-one, 1-(cyanomethyl)-cycloprop-1-yl-methyl, (1,1-dioxidothietan-2-yl)methyl, ((R)-1,1- dioxidothietan-2-yl)methyl, ((S)-1,1-dioxidothietan-2-yl)methyl, 1-(Fluoromethyl)- cycloprop-1-yl-methyl, 1-hydroxyl-cycloprop-1-yl-methyl, isoxazol-5-yl-methyl, (1-methyl- 1H-imidazol-5-yl)-methyl, 1-methoxy-cycloprop-1y
  • R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl.
  • R 5 is -COOH.
  • R 5 is 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is selected from the group consisting of -NH-, -N(Me)-, -N(Et)-, -OCH 2 -, -OC(H,Me)-, -CH 2 O-, -OCH 2 (cyclopropyl)-, -O-CH 2 -CH 2 -, -CH 2 -O-CH 2 -, - CH2-O-C((CH3)2), -NHCH2-, -CH2NH-, -N(Me)CH2-, and -SO2NH-.
  • L 1 is -CH2NH-.
  • L 1 is -O-; and L 2 is -C(O)-.
  • L 1 is -O-; and L 2 is - CH 2 -.
  • L 1 is -O-; and L 2 is -N(Me)-.
  • L 1 is -O-; L 2 is -SO 2 -; and L 3 is -CH 2 -.
  • L 1 is -O-; L 2 is -C(O)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -CH 2 -; L 3 is - CH2-; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -SO2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is - O-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -C(O)-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is - SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl.
  • L 1 is -O-; L 2 is -CH2-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl.
  • L 1 is - O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)- oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is - N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -CH 2 -; L 3 is -CH 2 - ; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is - O-;
  • L 2 is -NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , - OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • any of Formulas (LVII) - (LXIV) is (1- methyl-1H-imidazol-5-yl)-methyl.
  • R 4 is 1-methoxy-cycloprop-1yl-methyl.
  • R 4 is methoxyethan-2-yl.
  • R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2- yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2- cyclopropoxypropyl.
  • R 4 is (S)- 2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2- (2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -CH2O-; and L 2 is -C(O)-.
  • L 1 is -CH2O-; and L 2 is -CH2-.
  • L 1 is -CH 2 O-; and L 2 is -SO2-.
  • L 1 is -CH2O-; and L 2 is -NH-.
  • L 1 is -CH 2 O-; and L 2 is -N(Me)-.
  • L 1 is - CH 2 O-; L 2 is -C(O)-; and L 3 is -CH 2 -.
  • L 1 is -CH2O-; L 2 is -CH2-; and L 3 is -CH2-.
  • L 1 is -CH2O-; L 2 is -SO2-; and L 3 is - CH 2 -.
  • L 1 is -CH 2 O-; L 2 is -NH- -; and L 3 is -CH2-.
  • L 1 is - CH 2 O-; L 2 is -N(Me)- -; and L 3 is -CH 2 -.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 O-; L 2 is -CH 2 -; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH2O-; L 2 is -SO2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 O-; L 2 is -N(Me)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is - CH2O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH 2 O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl.
  • L 1 is -CH2O-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2- yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is - CH2O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -CH 2 O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 O-; L 2 is - NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is - COOH.
  • L 1 is -CH 2 O-; L 2 is - N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - CH 2 O-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is -CH 2 -; and R 2 and R 3 are each H; R 4 is (2S)-oxetan- 2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -; and
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)- 1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)- 2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2- (2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -OCH 2 -; and L 2 is -C(O)-.
  • L 1 is -OCH2-; and L 2 is -CH 2 -.
  • L 1 is -OCH2-; and L 2 is -N(Me)-.
  • L 1 is -OCH 2 -; L 2 is -SO 2 -; and L 3 is - CH2-.
  • L 1 is -OCH 2 - ; L 2 is -N(Me)- ; and L 3 is -CH2-.
  • L 1 is -OCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OCH2-; L 2 is -CH2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -OCH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OCH2-; L 2 is -NH-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -OCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is - OCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH2-; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH 2 -; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH 2 -; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2- yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is - OCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and
  • R 5 is -COOH.
  • L 1 is -OCH2-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2- yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -;
  • L 2 is -SO 2 -;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH2-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -OCH2-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5- yl
  • L 1 is -OCH2-;
  • L 2 is -NH-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, - CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5- yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy- cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2- methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2- oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2- yl)methyl.
  • R 4 is ((S)-1,1- dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2- (2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -NH- and L 2 is -C(O)-.
  • L 1 is -NH- and L 2 is - CH 2 -.
  • L 1 is -NH-; and L 2 is - N(Me)-.
  • L 1 is -NH-; L 2 is -SO 2 -; and L 3 is -CH 2 -.
  • L 1 is -NH-; L 2 is -C(O)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -CH2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan- 2-yl-methyl.
  • L 1 is -NH-; L 2 is - CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl- methyl.
  • L 1 is -NH-; L 2 is - N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl.
  • L 1 is - NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl.
  • L 1 is -NH-; L 2 is - N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NH-; L 2 is -C(O)-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2- yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is -COOH.
  • L 1 is -NH-;
  • L 2 is -C(O)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-;
  • L 2 is -NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)- oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl
  • L 1 is -NH-;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-;
  • L 2 is -NH-;
  • L 3 is - CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1- methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2- yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2- cyclopropoxypropyl.
  • R 4 is (S)- 2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2- (2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -N(Me)- and L 2 is -C(O)-.
  • L 1 is -N(Me)- and L 2 is -CH 2 -. In certain embodiments of any of Formulas (LVII) - (LXIV), L 1 is -N(Me)- and L 2 is -SO2-. In certain embodiments of any of Formulas (LVII) - (LXIV), L 1 is -N(Me)-; and L 2 is -NH-. In certain embodiments of any of Formulas (LVII) - (LXIV), L 1 is -N(Me)-; and L 2 is -N(Me)-.
  • L 1 is -N(Me)-; L 2 is -C(O)-; and L 3 is -CH 2 -.
  • L 1 is -N(Me)-; L 2 is -CH2-; and L 3 is -CH2-.
  • L 1 is -N(Me)-; L 2 is -SO2-; and L 3 is -CH2-.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -N(Me)-; L 2 is -SO2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is - N(Me)-; L 2 is -N(Me)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)-; L 2 is - SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol- 5-yl)-methyl.
  • L 1 is -N(Me)-; L 2 is -SO2-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is - N(Me)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is - COOH.
  • L 1 is -N(Me)-; L 2 is - C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is - NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is - COOH.
  • L 1 is -N(Me)-; L 2 is - N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Me)-;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • any of Formulas (LVII) - (LXIV) is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -N(Me)-;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-; L 2 is -N(Me)-; L 3 is -CH2- ; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3- yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine- 3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)- azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1- (cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)- cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)- 1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)- 2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2- (2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -N(Et)-; and L 2 is -C(O)-.
  • L 1 is -N(Et)-; and L 2 is -CH 2 -.
  • L 1 is -N(Et)-; and L 2 is -SO 2 -.
  • L 2 is -N(Et)-; and L 2 is -NH-.
  • L 1 is -N(Et)-; and L 2 is -N(Me)-.
  • L 1 is -N(Et)-; L 2 is -C(O)-; and L 3 is -CH2-.
  • L 1 is -N(Et)-; L 2 is -SO2-; and L 3 is -CH2-.
  • L 3 is -CH2-.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; and L 3 is -CH2-.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -N(Et)-; L 2 is -SO 2 -; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -SO2-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-mehyl.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is - N(Et)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl.
  • L 1 is -N(Et)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • any of Formulas (LVII) - (LXIV) is -N(Et)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2- yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is - SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -CH2-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -SO2-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and
  • R 5 is -COOH.
  • L 1 is -N(Et)-;
  • L 2 is -C(O)-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Et)-;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-;
  • L 2 is -SO 2 -;
  • L 3 is - CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Et)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)- oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-;
  • L 2 is -C(O)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • any of Formulas (LVII) - (LXIV) is -N(Et)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -N(Et)-;
  • L 2 is -SO2-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Et)-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, -CN, - C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1- methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2- yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2- cyclopropoxypropyl.
  • R 4 is (S)- 2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2- (2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -NHCH2-; and L 2 is -C(O)-.
  • L 1 is -NHCH 2 -; and L 2 is -CH2-.
  • L 1 is -NHCH2-; and L 2 is -SO2-.
  • any of Formulas (LVII) - (LXIV) is -NHCH2-; and L 2 is -N(Me)-.
  • L 1 is -NHCH 2 -; L 2 is -C(O)-; and L 3 is -CH 2 -.
  • L 1 is -NHCH2-; L 2 is -CH2-; and L 3 is -CH2-.
  • L 1 is -NHCH2-; L 2 is - SO 2 -; and L 3 is -CH 2 -.
  • L 1 is - NHCH2-; L 2 is -NH-; and L 3 is -CH2-.
  • L 1 is -NHCH 2 -; L 2 is -N(Me)-; and L 3 is -CH 2 -.
  • L 1 is -NHCH2-; L 2 is -C(O)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NHCH 2 -; L 2 is - CH2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NHCH2-; L 2 is -SO2-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -NHCH2-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NHCH 2 -; L 2 is -N(Me)-; L 3 is - CH2-; and R 2 and R 3 are each H.
  • L 1 is -NHCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is - NHCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NHCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NHCH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NHCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is - NHCH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl.
  • L 1 is -NHCH 2 -; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NHCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NHCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NHCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NHCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl- methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is - NHCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is - NHCH 2 -;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; ; and
  • R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and
  • R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NHCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - NHCH 2 -;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NHCH 2 -;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -NHCH 2 -; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -NHCH2-;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NHCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -NHCH 2 -; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas ((LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5- yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy- cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2- methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2- oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2- yl)methyl.
  • R 4 is ((S)-1,1- dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -CH2NH-; and L 2 is -C(O)-.
  • L 1 is -CH 2 NH-; and L 2 is -CH2-.
  • L 1 is -CH2NH-; and L 2 is -SO2-.
  • L 1 is -CH 2 NH-; and L 2 is -NH-.
  • any of Formulas (LVII) - (LXIV) is -CH2NH-; and L 2 is -N(Me)-.
  • L 1 is -CH 2 NH-; L 2 is -C(O)-; and L 3 is -CH 2 -.
  • L 1 is -CH2NH-; L 2 is -CH2-; and L 3 is -CH2-.
  • L 1 is -CH2NH-; L 2 is - SO 2 -; and L 3 is -CH 2 -.
  • L 1 is - CH2NH-; L 2 is -NH-; and L 3 is -CH2-.
  • L 1 is -CH 2 NH-; L 2 is -N(Me)-; and L 3 is -CH 2 -.
  • L 1 is -CH2NH-; L 2 is -C(O)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 NH-; L 2 is - CH2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH2NH-; L 2 is -SO2-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH2NH-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 NH-; L 2 is -N(Me)-; L 3 is - CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is - CH 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is - CH2NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl.
  • L 1 is -CH 2 NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl- methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is - CH 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is - CH 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; ; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is-CH 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 - ; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, - CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas ((LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1- methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl- 1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -N(Me)CH2-; and L 2 is -C(O)-.
  • L 1 is - N(Me)CH2-; and L 2 is -CH2-.
  • L 1 is -N(Me)CH2-; and L 2 is -SO2-.
  • L 1 is -N(Me)CH 2 -; and L 2 is -NH-.
  • L 1 is -N(Me)CH2-; and L 2 is -N(Me)-.
  • L 1 is -N(Me)CH 2 -; L 2 is -C(O)-; and L 3 is -CH 2 -.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; and L 3 is -CH 2 -.
  • L 1 is -N(Me)CH 2 -; L 2 is -SO 2 -; and L 3 is -CH 2 -.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; and L 3 is -CH2-.
  • L 1 is -N(Me)CH 2 -; L 2 is -N(Me)-; and L 3 is -CH2-.
  • L 1 is -N(Me)CH2-; L 2 is -C(O)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -N(Me)CH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; L 3 is - CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -N(Me)CH2-; L 2 is -N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -N(Me)CH 2 -; L 2 is -C(O)-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)CH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)CH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2- yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -N(Me)-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-;
  • L 2 is -N(Me)-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and
  • R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH 2 -;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)- oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Me)CH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH2-;
  • L 2 is - N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH2-;
  • L 2 is -C(O)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH 2 -; L 2 is -CH 2 -; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -N(Me)CH2-;
  • L 2 is -SO2-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH 2 -; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5- yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy- cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2- methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2- oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2- yl)methyl.
  • R 4 is ((S)-1,1- dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -OC(H,Me)-; and L 2 is -C(O)-.
  • L 1 is - OC(H,Me)-; and L 2 is -CH2-.
  • L 1 is -OC(H,Me)- and L 2 is -SO2-.
  • L 1 is -OC(H,Me)-; and L 2 is -NH-.
  • L 1 is -OC(H,Me)-; and L 2 is -N(Me)-.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; and L 3 is -CH 2 -.
  • L 1 is -OC(H,Me)-; L 2 is -CH2-; and L 3 is -CH 2 -.
  • L 1 is -OC(H,Me)-; L 2 is -SO 2 -; and L 3 is -CH 2 -.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; and L 3 is -CH2-.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; and L 3 is -CH2-.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OC(H,Me)-; L 2 is -SO 2 -; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is - CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2- yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan- 2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl- methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol- 5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and
  • R 5 is -COOH.
  • L 1 is -OC(H,Me)-;
  • L 2 is -C(O)-;
  • L 3 is - CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - OC(H,Me)-;
  • L 2 is -CH2-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -SO 2 -;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan- 2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -N(Me)-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - OC(H,Me)-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl
  • L 1 is -OC(H,Me)-;
  • L 2 is -SO2-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is - OC(H,Me)-;
  • L 2 is -NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop- 1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl.
  • R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2- cyclopropoxypropyl.
  • R 4 is (S)- 2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2- (2,2,2-trifluoroethoxy)ethyl.
  • R 4 is (R)-1,3-oxazol-2-yl-methyl .
  • R 4 is (R)-1,3-oxazol-2-yl-methyl .
  • L 1 is -SO2NH-; and L 2 is -C(O)-.
  • L 1 is -SO 2 NH-; and L 2 is -CH2-.
  • L 1 is - SO2NH-; and L 2 is -SO2-.
  • L 1 is -SO 2 NH-; and L 2 is -NH-.
  • L 1 is -SO2NH-; and L 2 is -N(Me)-.
  • L 1 is -SO2NH-; L 2 is -SO2-; and L 3 is - CH 2 -.
  • L 1 is -SO 2 NH-; L 2 is - NH-; and L 3 is -CH2-.
  • L 1 is - SO 2 NH-; L 2 is -N(Me)-; and L 3 is -CH 2 -.
  • L 1 is -SO2NH-; L 2 is -C(O)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -SO2NH-; L 2 is -SO2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -SO 2 NH-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -SO 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -SO2NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -SO2NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -SO2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -SO2NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -SO 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -SO 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -SO 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl.
  • L 1 is - SO 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl.
  • L 1 is -SO2NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -SO2NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -SO2NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -N(Me)-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -CH2-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and
  • R 5 is - COOH.
  • L 1 is -SO2NH-;
  • L 2 is - C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO 2 NH-;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2- yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO 2 NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -SO 2 NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO2NH-;
  • L 2 is -N(Me)-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - SO 2 NH-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl
  • L 1 is - SO 2 NH-;
  • L 2 is -NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO2NH-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -O-; L 2 is - C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -O-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -O-; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan- 3-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; ; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-;
  • L 2 is -C(O)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3- yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3- oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, - CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1- methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl- 1,3-diol . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH2O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH 2 O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH 2 O-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl- methyl.
  • L 1 is -CH2O-; L 2 is - CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol- 2-yl-methyl.
  • L 1 is -CH 2 O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -CH 2 O-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 O-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan- 3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -CH 2 O-;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl- methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - CH2O-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is - CH2O-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3- oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. [00175] In certain embodiments of any of Formulas (LVII) - (LXIV), L 1 is -OCH 2 -; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OCH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OCH2-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OCH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl- methyl.
  • L 1 is -OCH 2 -; L 2 is - CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -OCH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -OCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol- 2-yl-methyl.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -OCH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan- 3-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH 2 -; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH 2 -; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; ; and R 5 is -COOH.
  • L 1 is -OCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH 2 -;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl; and
  • R 5 is -COOH.
  • L 1 is -OCH 2 -;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -OCH2-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - OCH 2 -;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is - OCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH2-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is 1,3- oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop- 1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl .
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -NH-; L 2 is - C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NH- ; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NH- ; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -NH-; L 2 is -CH2-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2- yl-methyl.
  • L 1 is -NH-; L 2 is - NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl- methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is - SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; ; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl- methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is - N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-;
  • L 2 is -C(O)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -NH-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl- methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NH-; L 2 is -CH 2 -; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3- oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5- yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy- cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2- methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2- oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R4 is 3-(difluoromethyl)oxetan-3-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2- yl)methyl.
  • R 4 is ((S)-1,1- dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - N(Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - N(Me)-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl- methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; ; and R 5 is -COOH.
  • L 1 is - N(Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is - SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-; L 2 is -N(Me)-; L 3 is -CH 2 - ; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -N(Me)-;
  • L 2 is -CH2-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-;
  • L 2 is -NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Me)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-;
  • L 2 is -C(O)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3- oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl
  • L 1 is -N(Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-;
  • L 2 is -NH-;
  • L 3 is - CH2-;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5- yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy- cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2- methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2- oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2- yl)methyl.
  • R 4 is ((S)-1,1- dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -N(Et)-; L 2 is - C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)-;
  • L 2 is -NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol- 2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is - N(Et)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl- methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -SO 2 -; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; ; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3- oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)- ; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is - COOH.
  • L 1 is -N(Et)-; L 2 is - N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Et)-;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-;
  • L 2 is -SO2-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -N(Et)-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl- methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5- yl.
  • L 1 is -N(Et)-; L 2 is -CH2-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -N(Et)-;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5- yl.
  • L 1 is -N(Et)-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Et)-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2- yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, - C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1- methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl- 1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -NHCH2-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NHCH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NHCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NHCH 2 -; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NHCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -NHCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - NHCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -NHCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -NHCH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - NHCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl- methyl.
  • L 1 is -NHCH 2 -; L 2 is - C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -CH 2 -; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2- yl-methyl; ; and R 5 is -COOH.
  • L 1 is -NHCH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH2-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is - COOH.
  • L 1 is -NHCH2-; L 2 is - NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH2-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NHCH2-;
  • L 2 is -C(O)-;
  • L 3 is -CH2- ;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is - NHCH 2 -;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NHCH 2 -;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -NHCH 2 -; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NHCH2-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3- yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -NHCH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -NHCH2-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -NHCH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -NHCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, - OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl .
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -CH 2 NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - CH 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -CH2NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - CH2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl- methyl.
  • L 1 is -CH 2 NH-; L 2 is - C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -CH 2 -; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2- yl-methyl; ; and R 5 is -COOH.
  • L 1 is -CH2NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is - COOH.
  • L 1 is -CH2NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2NH-;
  • L 2 is -C(O)-;
  • L 3 is -CH2- ;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is - CH 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -CH 2 NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2NH-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3- yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2NH-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -CH2NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -CH 2 NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, - OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl .
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -N(Me)CH2-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan- 3-yl-methyl.
  • L 1 is - N(Me)CH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)CH 2 -; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -N(Me)CH 2 -; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)CH 2 -; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -N(Me)CH2-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3- yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH2-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is - N(Me)CH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH 2 -; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is - COOH.
  • L 1 is -N(Me)CH 2 -; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; ; and R 5 is - COOH.
  • L 1 is -N(Me)CH 2 -; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH 2 -; L 2 is -SO 2 -; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH 2 -; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH 2 -; L 2 is -N(Me)-; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -N(Me)CH 2 -; L 2 is -C(O)-; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is - N(Me)CH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH2-;
  • L 2 is -SO2-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH2-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH2-;
  • L 2 is -C(O)- ;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH2-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol- 2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is - N(Me)CH 2 -;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -N(Me)CH 2 -; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3- yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine- 3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)- azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1- (cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)- cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -CH2-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan- 3-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3- yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is - OC(H,Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is - COOH.
  • L 1 is -OC(H,Me)-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; ; and R 5 is - COOH.
  • L 1 is -OC(H,Me)-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -SO2-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OC(H,Me)-;
  • L 2 is -C(O)-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is - OC(H,Me)-;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -SO 2 -;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - OC(H,Me)-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -C(O)-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - OC(H,Me)-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -OC(H,Me)-;
  • L 2 is -SO 2 -;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol- 2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OC(H,Me)-; L 2 is -N(Me)-; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop- 1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl .
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -SO2NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -SO2NH-; L 2 is -CH2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -SO2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -SO 2 NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -SO 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is oxelan-3-yl-methyl.
  • L 1 is -SO 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - SO 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -SO2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl-methyl.
  • L 1 is -SO2NH-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3- oxazol-2-yl-methyl.
  • L 1 is - SO2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is 1,3-oxazol-2-yl- methyl.
  • L 1 is -SO 2 NH-; L 2 is - C(O)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO 2 NH-; L 2 is -CH 2 -; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO 2 NH-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO 2 NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO 2 NH-; L 2 is -C(O)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2- yl-methyl; ; and R 5 is -COOH.
  • L 1 is -SO 2 NH-; L 2 is -CH 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -SO 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is - COOH.
  • L 1 is -SO2NH-; L 2 is - NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -SO2NH-;
  • L 2 is -C(O)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -SO2NH-;
  • L 2 is -CH 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO2NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO2NH-; L 2 is -SO2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is oxelan-3-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -SO 2 NH-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO2NH-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is oxelan-3-yl- methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO2NH-;
  • L 2 is -C(O)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5- yl.
  • L 1 is -SO2NH-; L 2 is -CH2-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is 1,3-oxazol-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -SO 2 NH-;
  • L 2 is -SO 2 -;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5- yl.
  • L 1 is -SO 2 NH-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is 1,3-oxazol-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -SO2NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is 1,3-oxazol- 2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, - C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1- methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl- 1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -O-; and L 2 is -O-.
  • L 1 is -O-; and L 2 is -CF 2 -.
  • L 1 is -O-; and L 2 is -CHF-.
  • L 1 is -O-; and L 2 is -CH(OH)-.
  • L 1 is -O-; and L 2 is -N(Me)-.
  • L 1 is -O-; L 2 is -CH(OH)-; and L 3 is -CH2-.
  • L 1 is -O-; L 2 is -O-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -CF2-; L 3 is -CH2- ; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -CHF-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -CH(OH)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -NH-; L 3 is - CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -O-; L 2 is -O-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -O-; L 2 is -O-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -O-; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -O-; L 2 is -CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -O-; L 2 is -CH(OH)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl.
  • L 1 is - O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl.
  • L 1 is -O-; L 2 is -O-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -CHF-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl- methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -O-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -O-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is - CHF-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is - CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-; L 2 is - NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is - COOH.
  • L 1 is -O-; L 2 is - N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -O-;
  • L 2 is -CHF-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is -CH(OH)-;
  • L 3 is - CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - O-;
  • L 2 is -NH-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is -N(Me)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)- oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -O-; L 2 is -CHF-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-;
  • L 2 is -CH(OH)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF3, -OMe, -CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3- diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop- 1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1- (Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl- methyl.
  • R 4 is ⁇ [1-(1,2-oxazole- 3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-(difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -CH 2 O-; and L 2 is -O-.
  • L 1 is -CH2O-; and L 2 is -CF 2 -.
  • L 1 is -CH 2 O-; and L 2 is -CHF-.
  • L 1 is -CH2O-; and L 2 is -CH(OH)-.
  • L 1 is -CH 2 O-; and L 2 is -NH-.
  • L 1 is -CH2O-; and L 2 is -N(Me)-.
  • L 1 is -CH 2 O-; L 2 is -CF 2 -; and L 3 is -CH 2 -.
  • L 1 is -CH2O-; L 2 is -CHF-; and L 3 is -CH2-.
  • L 1 is -CH 2 O-; L 2 is -CH(OH)-; and L 3 is -CH2-.
  • L 1 is -CH2O-; L 2 is -O-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH2O-; L 2 is -CF2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 O-; L 2 is -CHF-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH 2 O-; L 2 is -CH(OH)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 O-; L 2 is - N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -CH 2 O-; L 2 is -O-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is - CH2O-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -CHF-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl- methyl.
  • L 1 is -CH 2 O-; L 2 is -O- ; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 O-; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 O-; L 2 is -CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 O-; L 2 is -CH(OH)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 O-; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl.
  • L 1 is -CH 2 O-; L 2 is -O-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is - COOH.
  • L 1 is -CH2O-; L 2 is - CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -CH(OH)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -O-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; ; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -CHF-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -CH(OH)-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -CH2O-; L 2 is -O-; L 3 is - CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is - CH 2 O-; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-;
  • L 2 is -CHF-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-;
  • L 2 is -CH(OH)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2- yl-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4- tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -O-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH 2 O-; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1- ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -CH 2 O-; L 2 is -CHF-; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-;
  • L 2 is -CH(OH)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -CH2O-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, - CN, -C(O)NMe2, alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)-azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1-(cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl- cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1- methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)-cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2- yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1- (1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl- methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl- 1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- (difluoromethyl)oxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2-yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3-fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4- methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3- oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1-methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2- trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -OCH 2 -; and L 2 is -O-.
  • L 1 is -OCH2-; and L 2 is -CF 2 -.
  • L 1 is -OCH 2 -; and L 2 is -CHF-.
  • L 1 is -OCH2-; and L 2 is -CH(OH)-.
  • L 1 is -OCH 2 -; and L 2 is -NH-.
  • L 1 is -OCH2-; and L 2 is -N(Me)-.
  • L 1 is - OCH2-; L 2 is -O-; and L 3 is -CH2-.
  • L 1 is -OCH 2 -; L 2 is -CH(OH)-; and L 3 is -CH2-.
  • L 1 is -OCH2-; L 2 is - NH-; and L 3 is -CH 2 -.
  • L 1 is -OCH 2 -; L 2 is -O-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OCH2-; L 2 is -CF2-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -OCH 2 -; L 2 is -CHF-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OCH2-; L 2 is -CH(OH)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -OCH 2 -; L 2 is - NH-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -OCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -OCH2-; L 2 is -O-; L 3 is - CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH2-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH2-; L 2 is -CHF-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is - OCH2-; L 2 is -CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl- methyl.
  • L 1 is -OCH 2 -; L 2 is - NH-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH 2 -; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -OCH 2 -; L 2 is -O-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH 2 -; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl- 1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH 2 -; L 2 is -CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol- 5-yl)-methyl.
  • L 1 is -OCH2-; L 2 is -CH(OH)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl.
  • L 1 is -OCH2-; L 2 is - NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -OCH2-; L 2 is -O-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CHF-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (2S)-oxetan- 2-yl-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -O-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CHF-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -NH-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5- yl)-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol- 5-yl)-methyl; and R 5 is -COOH.
  • L 1 is -OCH2-;
  • L 2 is -CHF-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -;
  • L 2 is -CH(OH)-;
  • L 3 is -CH 2 -;
  • R 2 and R 3 are each H;
  • R 4 is (2S)- oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is tetrazolyl, for instance 1H- 1,2,3,4-tetrazol-5-yl.
  • L 1 is - OCH2-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (2S)-oxetan-2-yl-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH2-; L 2 is -CF2-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl
  • L 1 is -OCH 2 -; L 2 is -CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl; and R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH 2 -;
  • L 2 is -CH(OH)-;
  • L 3 is - CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH2-;
  • L 2 is -NH-;
  • L 3 is -CH2-;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • L 1 is -OCH2-;
  • L 2 is -N(Me)-;
  • L 3 is -CH2- ;
  • R 2 and R 3 are each H;
  • R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl;
  • R 5 is tetrazolyl, for instance 1H-1,2,3,4-tetrazol-5-yl.
  • R 1 can be selected from H, Cl, F, Me, -CF 3 , -OMe, -CN, -C(O)NMe 2 , alkyl, propyl, isopropyl, and cyclopropyl.
  • R 4 is azetidine-3- yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R)-azetidine- 3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3S)- azetidine-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is butan-1-yl-one.
  • R 4 is 1- (cyanomethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(Fluoromethyl)-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-hydroxyl-cycloprop-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is isoxazol-5-yl-methyl.
  • R 4 is (1-methyl-1H-imidazol-5-yl)-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-methoxy-cycloprop-1yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is methoxyethan-2-yl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-(2-methoxyethyl)- cycloprop-1-yl-methyl.
  • R 4 is ⁇ [1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2R)-1-(1,2-oxazole-3-carbonyl)azetidin-2-yl]methyl ⁇ . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ⁇ [(2S)-1-(1,2-oxazole-3- carbonyl)azetidin-2-yl]methyl.
  • R 4 is 2-oxabicyclo[2.1.1]hexa-1-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-buta-4-yl-1,3-diol. In certain embodiments of any of Formulas (LVII) - (LXIV), R4 is 3-(difluoromethyl)oxetan-3-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is ((R)-1,1-dioxidothietan-2-yl)methyl.
  • R 4 is ((S)-1,1-dioxidothietan-2- yl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 3- fluorooxetan-3-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (3R,4R)-4-methoxytetrahydrofuran-3-yl.
  • R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (S)-1,3-oxazol-2-yl-methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-1,3-oxazol-2-yl-methyl . In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 1-cyclobutylmethyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (R)-2-cyclopropoxypropyl.
  • R 4 is (S)-2-cyclopropoxypropyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(difluoromethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-oxolan-2-yl-methyl.
  • R 4 is (1- methoxycyclobutyl)methyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2R)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is (2S)-2-(2,2,2-trifluoroethoxy)propyl. In certain embodiments of any of Formulas (LVII) - (LXIV), R 4 is 2-(2,2,2-trifluoroethoxy)ethyl.
  • L 1 is -NH- and L 2 is -O-.
  • L 1 is -NH- and L 2 is -CF2- .
  • L 1 is -NH-; and L 2 is -CHF-.
  • L 1 is -NH-; and L 2 is - CH(OH)-.
  • L 1 is -NH-; and L 2 is - N(Me)-.
  • L 1 is -NH-; L 2 is -O-; and L 3 is -CH 2 -.
  • L 1 is -NH-; L 2 is -CF2-; and L 3 is -CH2-.
  • L 1 is -NH-; L 2 is -CHF-; and L 3 is -CH 2 -.
  • L 1 is -NH-; L 2 is -CH(OH)-; and L 3 is -CH2-.
  • L 1 is -NH-; L 2 is -O-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -CF 2 -; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -CHF-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -CH(OH)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -NH-; L 3 is -CH 2 -; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; and R 2 and R 3 are each H.
  • L 1 is -NH-; L 2 is -O-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -CF 2 -; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -CH(OH)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)- oxetan-2-yl-methyl.
  • L 1 is -NH- ; L 2 is -NH-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (2S)-oxetan-2-yl-methyl.
  • L 1 is -NH-; L 2 is -O-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NH-; L 2 is -CF2-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H- imidazol-5-yl)-methyl.
  • L 1 is - NH-; L 2 is -CHF-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)- methyl.
  • L 1 is -NH-; L 2 is - CH(OH)-; L 3 is -CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NH-; L 2 is -NH-; L 3 is - CH2-; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NH-; L 2 is -N(Me)-; L 3 is -CH 2 -; R 2 and R 3 are each H; and R 4 is (1-ethyl-1H-imidazol-5-yl)-methyl.
  • L 1 is -NH-; L 2 is -O-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -CF 2 -; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -CHF-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)- oxetan-2-yl-methyl; and R 5 is -COOH.
  • L 1 is -NH-; L 2 is -CH(OH)-; L 3 is -CH 2 -; R 2 and R 3 are each H; R 4 is (2S)-oxetan-2- yl-methyl; and R 5 is -COOH.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP23755311.0A 2022-07-27 2023-07-26 N-heterocyclische gpcr-rezeptoragonisten, pharmazeutische zusammensetzungen damit und verfahren zu ihrer verwendung Pending EP4562006A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263392857P 2022-07-27 2022-07-27
PCT/US2023/071000 WO2024026338A1 (en) 2022-07-27 2023-07-26 N-heterocylic gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use

Publications (1)

Publication Number Publication Date
EP4562006A1 true EP4562006A1 (de) 2025-06-04

Family

ID=87576103

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23755311.0A Pending EP4562006A1 (de) 2022-07-27 2023-07-26 N-heterocyclische gpcr-rezeptoragonisten, pharmazeutische zusammensetzungen damit und verfahren zu ihrer verwendung

Country Status (5)

Country Link
EP (1) EP4562006A1 (de)
JP (1) JP2025525010A (de)
CN (1) CN119923395A (de)
TW (1) TW202417433A (de)
WO (1) WO2024026338A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025057134A2 (en) 2023-09-14 2025-03-20 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
US12291530B1 (en) 2023-11-24 2025-05-06 Ascletis Pharma (China) Co., Limited GLP-1R agonist and therapeutic method thereof
WO2025128561A1 (en) * 2023-12-11 2025-06-19 Carmot Therapeutics, Inc. Crystalline forms of a glp-1 receptor modulator
WO2025158275A1 (en) 2024-01-24 2025-07-31 Pfizer Inc. Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds
WO2025189141A1 (en) 2024-03-08 2025-09-12 Annapurna Bio, Inc. Methods for treating obesity and increasing weight loss
WO2025259888A1 (en) * 2024-06-13 2025-12-18 Carmot Therapeutics Inc. Method of treating diabetes using a glp-1 receptor agonist
WO2026013531A1 (en) * 2024-07-10 2026-01-15 Pfizer Inc. Spiro[2.5]octane compounds
WO2026047102A1 (en) 2024-08-29 2026-03-05 F. Hoffmann-La Roche Ag Process for the preparation of pyrimidine derivatives
WO2026059341A1 (ko) * 2024-09-11 2026-03-19 한미약품 주식회사 Glp-1 수용체 작용제 및 이의 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275288A1 (en) 2005-01-20 2006-12-07 Grihalde Nelson D GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
US20120148586A1 (en) 2009-08-27 2012-06-14 Joyce Ching Tsu Chou Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
US20120021979A1 (en) 2010-06-24 2012-01-26 Vanderbilt University GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
JP7053900B2 (ja) * 2018-06-15 2022-04-12 ファイザー・インク Ｇｌｐ－１受容体アゴニストおよびその使用
MA54555A (fr) * 2018-11-22 2021-09-29 Qilu Regor Therapeutics Inc Agonistes de glp-1r et leurs utilisations
WO2021018023A1 (zh) * 2019-08-01 2021-02-04 济南泰达领创医药技术有限公司 小分子glp-1受体调节剂
EP4058445B1 (de) * 2019-11-15 2025-03-26 Ildong Pharmaceutical Co., Ltd. Glp-1-rezeptoragonisten und verwendung davon
EP4103563A4 (de) * 2020-02-13 2024-03-06 Gasherbrum Bio, Inc. Heterocyclische glp-1-agonisten
TW202144340A (zh) * 2020-04-03 2021-12-01 大陸商江蘇恆瑞醫藥股份有限公司 稠合咪唑類衍生物、其製備方法及其在醫藥上的應用
JP2023538949A (ja) * 2020-08-28 2023-09-12 ガシャーブラム・バイオ・インコーポレイテッド ヘテロ環ｇｌｐ－１アゴニスト
US20250263402A1 (en) * 2020-10-12 2025-08-21 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Benzimidazolone glp-1 receptor agonist and use thereof
EP4229050A4 (de) * 2020-10-13 2024-12-11 Gasherbrum Bio, Inc. Heterocyclische glp-1-agonisten
WO2022078380A1 (en) * 2020-10-13 2022-04-21 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
US11851419B2 (en) * 2020-11-20 2023-12-26 Gilead Sciences, Inc. GLP-1R modulating compounds
CR20230330A (es) * 2021-01-28 2023-11-15 Carmot Therapeutics Inc Agonistas del receptor gpcr, composiciones farmaceuticas que los comprenden y métodos para su uso
BR112023022836A2 (pt) * 2021-05-03 2024-01-16 Carmot Therapeutics Inc Agonistas de receptores de glp-1 benzimidazoíla, composições farmacêuticas que compreendem os mesmos e métodos para seu uso

Also Published As

Publication number Publication date
TW202417433A (zh) 2024-05-01
JP2025525010A (ja) 2025-08-01
WO2024026338A1 (en) 2024-02-01
CN119923395A (zh) 2025-05-02

Similar Documents

Publication Publication Date Title
WO2024026338A1 (en) N-heterocylic gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
EP4563199A2 (de) Gpcr-rezeptoragonisten, pharmazeutische zusammensetzungen damit und verfahren zu ihrer verwendung
EP4334304A1 (de) Benzimidazoyl-glp-1-rezeptoragonisten, pharmazeutische zusammensetzungen damit und verfahren zu deren verwendung
WO2022199661A1 (en) Phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-phenyl-, phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-heteroaryl-, or phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo [d] imidazole-carboxylic acid derivatives and methods of using same
JP6618120B2 (ja) ＴｒｋＡ阻害活性を有する複素環および炭素環誘導体
JP2024514259A (ja) Ｇｌｐ－１受容体作動薬、それを含む薬学的組成物、およびその製造方法
CN113501821B (zh) 具有mgat-2抑制活性的稠合环衍生物
KR20240053617A (ko) Glp1r 작용제로서의 신규 아릴 에테르 치환 헤테로시클릭 화합물
WO2019006126A1 (en) KINASE INHIBITORS AND METHODS OF MAKING AND USING THEM
WO2017006953A1 (ja) ＴｒｋＡ阻害活性を有する複素環誘導体
WO2018079759A1 (ja) ＴｒｋＡ阻害活性を有する縮合複素環および縮合炭素環誘導体
JPWO2018021447A1 (ja) ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物
WO2017204316A1 (ja) ５－オキソ－１，２，４－トリアジン誘導体およびその医薬組成物
CN117043154A (zh) Gpcr受体激动剂、包含其的药物组合物以及它们的使用方法
HK40120799A (zh) N-杂环gpcr受体激动剂、包含其的药物组合物和其使用方法
CN117545748A (zh) 苯并咪唑基glp-1gpcr受体激动剂、包含其的药物组合物以及它们的使用方法
WO2017209267A1 (ja) プリン誘導体
EA051557B1 (ru) Агонисты рецепторов gpcr, содержащие их фармацевтические композиции, и способы их применения
JP2019127467A (ja) ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物を含有する医薬組成物
WO2023069721A2 (en) Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28
JP2019189573A (ja) 縮合複素環および縮合炭素環誘導体を含有する、疼痛の治療および／または予防用医薬組成物

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250127

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)